Literature DB >> 18419528

Seasonality of antibiotic-resistant streptococcus pneumoniae that causes acute otitis media: a clue for an antibiotic-restriction policy?

Ron Dagan1, Galia Barkai, Noga Givon-Lavi, Amir Z Sharf, Daniel Vardy, Ted Cohen, Marc Lipsitch, David Greenberg.   

Abstract

BACKGROUND: It is unclear whether reducing antibiotic prescriptions can reduce rates of resistance once resistance becomes prevalent. We attempted to determine whether reduced antibiotic consumption, which is observed yearly in children during the warm season, is associated with a reduction in antibiotic resistance in pneumococcal acute otitis media (AOM).
METHODS: Antibiotic prescriptions and resistance were measured prospectively during 1999-2003 in 2 demographically distinct populations: Jewish and Bedouin children (aged <5 years) in southern Israel. Associations were assessed using seasonally clustered logistic regression models.
RESULTS: The study included 236,466 prescriptions and 3609 pneumococcal isolates. Prescription rates decreased during the warm months by 36% and 15% in Jewish and Bedouin children, respectively (P < .001 for the season). Among Jewish children, higher resistance rates were observed during the cold than the warm months (P < .001 for each antibiotic). This difference remained significant after adjustment for age, ethnic group, study year, history of antibiotic use, and serotype. The difference was not observed in Bedouin children.
CONCLUSIONS: Rapid seasonal decline in resistant AOM-causing pneumococci occurred only in Jewish children, among whom a marked prescribing seasonality was noted, and not in Bedouin children, among whom prescription was less seasonal. The rapid seasonal decrease in resistance associated with markedly reduced antibiotic use suggests that drug-resistant pneumococci may pay a fitness cost.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18419528      PMCID: PMC2652754          DOI: 10.1086/528995

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  32 in total

1.  Changes in antibiotic-prescribing practices and carriage of penicillin-resistant Streptococcus pneumoniae: A controlled intervention trial in rural Alaska.

Authors:  Thomas W Hennessy; Kenneth M Petersen; Dana Bruden; Alan J Parkinson; Debby Hurlburt; Marilyn Getty; Benjamin Schwartz; Jay C Butler
Journal:  Clin Infect Dis       Date:  2002-05-21       Impact factor: 9.079

2.  Fitness costs of fluoroquinolone resistance in Streptococcus pneumoniae.

Authors:  Daniel E Rozen; Lesley McGee; Bruce R Levin; Keith P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

3.  Antibiotic use: the crystal ball for predicting antibiotic resistance.

Authors:  Annalisa Pantosti; Maria Luisa Moro
Journal:  Clin Infect Dis       Date:  2005-03-31       Impact factor: 9.079

4.  The population genetics of antibiotic resistance.

Authors:  B R Levin; M Lipsitch; V Perrot; S Schrag; R Antia; L Simonsen; N M Walker; F M Stewart
Journal:  Clin Infect Dis       Date:  1997-01       Impact factor: 9.079

Review 5.  Treatment of acute otitis media - challenges in the era of antibiotic resistance.

Authors:  R Dagan
Journal:  Vaccine       Date:  2000-12-08       Impact factor: 3.641

6.  Emergence and persistence of macrolide resistance in oropharyngeal flora and elimination of nasal carriage of Staphylococcus aureus after therapy with slow-release clarithromycin: a randomized, double-blind, placebo-controlled study.

Authors:  Hans F Berg; Jeroen H T Tjhie; Gert-Jan Scheffer; Marcel F Peeters; Peter H J van Keulen; Jan A J W Kluytmans; Ellen E Stobberingh
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

7.  Outpatient antibiotic use in Europe and association with resistance: a cross-national database study.

Authors:  Herman Goossens; Matus Ferech; Robert Vander Stichele; Monique Elseviers
Journal:  Lancet       Date:  2005 Feb 12-18       Impact factor: 79.321

Review 8.  Hidden epidemic of macrolide-resistant pneumococci.

Authors:  Keith P Klugman; John R Lonks
Journal:  Emerg Infect Dis       Date:  2005-06       Impact factor: 6.883

9.  Community prescribing and resistant Streptococcus pneumoniae.

Authors:  Galia Barkai; David Greenberg; Noga Givon-Lavi; Eli Dreifuss; Daniel Vardy; Ron Dagan
Journal:  Emerg Infect Dis       Date:  2005-06       Impact factor: 6.883

10.  Relative fitness of fluoroquinolone-resistant Streptococcus pneumoniae.

Authors:  Crystal N Johnson; David E Briles; William H Benjamin; Susan K Hollingshead; Ken B Waites
Journal:  Emerg Infect Dis       Date:  2005-06       Impact factor: 6.883

View more
  40 in total

1.  Cervicitis of unknown etiology.

Authors:  Stephanie N Taylor
Journal:  Curr Infect Dis Rep       Date:  2014-07       Impact factor: 3.725

2.  Development and evaluation of an ontology for guiding appropriate antibiotic prescribing.

Authors:  Tiffani J Bright; E Yoko Furuya; Gilad J Kuperman; James J Cimino; Suzanne Bakken
Journal:  J Biomed Inform       Date:  2011-10-11       Impact factor: 6.317

3.  Variations in outpatient antimicrobial use between and within countries: an ongoing mystery.

Authors:  B Huttner; S Harbarth
Journal:  Infection       Date:  2010-02       Impact factor: 3.553

4.  Seasonal variation in penicillin use in Mexico and Brazil: analysis of the impact of over-the-counter restrictions.

Authors:  Yared Santa-Ana-Tellez; Aukje K Mantel-Teeuwisse; Hubert G M Leufkens; Veronika J Wirtz
Journal:  Antimicrob Agents Chemother       Date:  2014-10-13       Impact factor: 5.191

5.  Deciphering the Impact of Bystander Selection for Antibiotic Resistance in Neisseria gonorrhoeae.

Authors:  Scott W Olesen; Yonatan H Grad
Journal:  J Infect Dis       Date:  2020-03-16       Impact factor: 5.226

6.  Azithromycin Susceptibility Among Neisseria gonorrhoeae Isolates and Seasonal Macrolide Use.

Authors:  Scott W Olesen; Elizabeth A Torrone; John R Papp; Robert D Kirkcaldy; Marc Lipsitch; Yonatan H Grad
Journal:  J Infect Dis       Date:  2019-01-29       Impact factor: 5.226

Review 7.  Long-term macrolide therapy in chronic obstructive pulmonary disease.

Authors:  Ganapathi Iyer Parameswaran; Sanjay Sethi
Journal:  CMAJ       Date:  2014-08-05       Impact factor: 8.262

8.  A decade of outpatient antimicrobial use in older adults in Ontario: a descriptive study.

Authors:  Charlie Tan; Erin Graves; Hong Lu; Anna Chen; Shudong Li; Kevin L Schwartz; Nick Daneman
Journal:  CMAJ Open       Date:  2017-12-21

9.  Prevalence and treatment outcome of cervicitis of unknown etiology.

Authors:  Stephanie N Taylor; Shelly Lensing; Jane Schwebke; Rebecca Lillis; Leandro A Mena; Anita L Nelson; Anne Rinaldi; Lisa Saylor; Linda McNeil; Jeannette Y Lee
Journal:  Sex Transm Dis       Date:  2013-05       Impact factor: 2.830

10.  What is the mechanism for persistent coexistence of drug-susceptible and drug-resistant strains of Streptococcus pneumoniae?

Authors:  Caroline Colijn; Ted Cohen; Christophe Fraser; William Hanage; Edward Goldstein; Noga Givon-Lavi; Ron Dagan; Marc Lipsitch
Journal:  J R Soc Interface       Date:  2009-11-25       Impact factor: 4.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.